openPR Logo
Press release

Rising Geriatric Population Proliferates Brain Health Supplements Demand

08-29-2022 12:50 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: P&S Intelligence

Rising Geriatric Population Proliferates Brain Health

The brain health supplements market contributed $7,910.1 million in 2021, and it is projected to advance at a rate of 7.8% and capture $15,525 million in 2030. The rising demand for health supplements is projected to enhance attention, memory, and the ability for stress management, more specifically among the elderly population boosts the industry.

The worldwide rising trend of veganism massively impacts the landscape of food and vitamin supplement. Consumers turning vegan are opting for plant-based omega-3 supplements to maintain a healthy lifestyle. In the past few years, veganism has fetched people's interest tremendously. The fish oil is highly being replaced by omega-3 sourced from algae for its nutritional value and taste.

The memory enhancement category holds the largest share of the brain health supplements industry, accounting for 30%. It is ascribed to the growing awareness of mental health. According to Alzheimer's Disease International report, around 55 million people were suffering from dementia in 2020. In addition, it is predicted that 78 million people would be living with dementia in 2030, and 139 million are predicted to experience dementia conditions in 2050.

Request for sample pages of this report: https://www.psmarketresearch.com/market-analysis/brain-health-supplement-market/report-sample

According to WHO, Alzheimer's disease would result in 70% of cases of dementia globally. The growing awareness of such diseases is projected to boost the demand for supplements for maintaining a strong memory.

The depression & mood category is projected to experience the fastest growth. Depression can happen to anyone, irrespective of age. The elderly population is more likely to suffer from depression. The rising prevalence of depression and growing understanding of measures for its prevention and alleviation drives the industry.

Moreover, stress & anxiety is the next-fastest growing category in the industry. Around one in every three persons aging from 13 to 18 experience anxiety at some point in time, according to a government agency. According to WHO, COVID-19 has caused an increase of the 25% in anxiety and depression prevalence globally. The rising levels of stress and anxiety are projected to result in its growth in the near future.

The busy and hectic schedule of people has made them switch from physical purchasing to online shopping. The product reviews and information relevant to products available on online platforms help in making purchase decisions. Moreover, during a pandemic, the supplement companies opened new sales channels to expand their consumer base, when people remained at home due to lockdown.

The herbal brain supplements utilize plant-based and natural ingredients such as curcumin, ginkgo Biloba, and green tea extracts to sharpen memory and increase the blood flow to the brain, thus improving cognitive functioning and reducing mental tiredness.

Browse full report at: https://www.psmarketresearch.com/market-analysis/brain-health-supplement-market

The growing requirement for brain supplements with herbal extracts will increase the preference for herbal products in emerging economies, such as India and China. In the U.S. and Europe, herbal medicines utilized in traditional Chinese medicine are often marketed as supplements. Therefore, the herbal extract category is projected to witness the highest growth in the coming future.

Therefore, the vitamins and minerals category are projected to experience the highest growth in the coming future, as they are necessary for the proper functioning of the brain. For instance, B1 facilitates brain nerve communication, and B2 causes relief from headaches and increases energy production, while B9 enhances brain health and mood.

Thus, the rising elderly population more prone to memory disorders and depression boosts the demand for brain health supplements.

Contact:
P&S Intelligence
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Follow Us: https://www.linkedin.com/company/pnsintelligence/

P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising Geriatric Population Proliferates Brain Health Supplements Demand here

News-ID: 2718965 • Views:

More Releases from P&S Intelligence

U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period. According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sectors
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period. This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by Omnichannel Integration
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, and Growth Opportunities
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, an …
According to the latest market research study published by P&S Intelligence, the global industrial starches market is poised for significant growth, with a projected increase from USD 110.3 billion in 2024 to USD 169.9 billion by 2030, at a robust compound annual growth rate (CAGR) of 7.5%. Industrial starches play a crucial role in diverse sectors, including food, pharmaceuticals, and paper, driven by their unique properties such as stabilizing, thickening,

All 4 Releases


More Releases for Alzheimer

Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion. Data Bridge
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports. Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as